Corient Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $4.44M | Hold |
8,173
| – | – | 0.33% | 69 |
|
|
2022
Q2 | $4.44M | Buy |
8,173
+861
| +12% | +$468K | 0.34% | 73 |
|
|
2022
Q1 | $4.32M | Buy |
7,312
+304
| +4% | +$180K | 0.29% | 85 |
|
|
2021
Q4 | $4.68M | Buy |
7,008
+200
| +3% | +$133K | 0.31% | 81 |
|
|
2021
Q3 | $3.89M | Buy |
6,808
+368
| +6% | +$210K | 0.28% | 82 |
|
|
2021
Q2 | $3.25M | Buy |
6,440
+372
| +6% | +$188K | 0.24% | 90 |
|
|
2021
Q1 | $2.77M | Buy |
6,068
+217
| +4% | +$99.1K | 0.24% | 86 |
|
|
2020
Q4 | $2.73M | Sell |
5,851
-2,551
| -30% | -$1.19M | 0.27% | 83 |
|
|
2020
Q3 | $3.71M | Sell |
8,402
-138
| -2% | -$60.9K | 0.43% | 57 |
|
|
2020
Q2 | $3.09M | Buy |
8,540
+885
| +12% | +$321K | 0.38% | 65 |
|
|
2020
Q1 | $2.17M | Buy |
7,655
+1,063
| +16% | +$301K | 0.34% | 77 |
|
|
2019
Q4 | $2.14M | Buy |
6,592
+138
| +2% | +$44.8K | 0.27% | 82 |
|
|
2019
Q3 | $1.88M | Buy |
6,454
+988
| +18% | +$288K | 0.27% | 84 |
|
|
2019
Q2 | $1.61M | Buy |
5,466
+296
| +6% | +$87K | 0.25% | 102 |
|
|
2019
Q1 | $1.42M | Buy |
5,170
+2,074
| +67% | +$568K | 0.23% | 126 |
|
|
2018
Q4 | $693K | Buy |
3,096
+1,206
| +64% | +$270K | 0.12% | 181 |
|
|
2018
Q3 | $462K | Hold |
1,890
| – | – | 0.08% | 201 |
|
|
2018
Q2 | $392K | Buy |
1,890
+204
| +12% | +$42.3K | 0.07% | 207 |
|
|
2018
Q1 | $348K | Buy |
1,686
+28
| +2% | +$5.78K | 0.06% | 201 |
|
|
2017
Q4 | $315K | Buy |
1,658
+193
| +13% | +$36.7K | 0.05% | 228 |
|
|
2017
Q3 | $277K | Sell |
1,465
-23
| -2% | -$4.35K | 0.05% | 234 |
|
|
2017
Q2 | $260K | Sell |
1,488
-180
| -11% | -$31.5K | 0.04% | 271 |
|
|
2017
Q1 | $256K | Sell |
1,668
-154
| -8% | -$23.6K | 0.04% | 270 |
|
|
2016
Q4 | $257K | Sell |
1,822
-396
| -18% | -$55.9K | 0.05% | 272 |
|
|
2016
Q3 | $353K | Buy |
+2,218
| New | +$353K | 0.07% | 234 |
|